- Vapotherm Inc VAPO shares plunged almost 40% after the company reported disappointing Q3 FY22 earnings.
- Total revenue was $13.5 million, down 65% Y/Y and missing the consensus estimate of $16.54 million.
- Vapotherm reported a wider EPS loss of $(0.98) compared to $(0.52) a year ago and missing the Wall Street estimate of $(0.78).
- The company is evaluating various capital-raising options while it continues to execute its path-to-profitability initiative, which includes converting $20 million of excess inventory into cash.
- The company believes the combination of additional capital and converting up to $20 million of inventory into cash will allow it to fund its business through 2023 and get it to Adjusted EBITDA positive in Q4 of 2023.
- Guidance: For fiscal 2022, Vapotherm expects sales of $64-$66 million, down from prior guidance of $76-$81 million.
- The company says that the guidance reflects a light flu season and does not reflect any significant COVID impact.
- Vapotherm expects a gross margin of 22%-24%, a decrease from the previous range of 30%-32%.
- Price Action: VAPO shares are down 38.60% at $1.29 on the last check Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in